BlackLine Announces Third Quarter Financial Results GlobeNewswire November 06, 2025 LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced financial results for the third quarter ended September 30, 2025. “BlackLine's third-quarter results, with increasing revenue growth, solid margins, and strong free cash flow, demonstrate that our focus on improved execution […]

Zymeworks Provides Corporate Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 Encouraging Phase 1 data on ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-⺠(FRâº), presented at the AACR-NCI-EORTC Conference First patient dosed in Phase 1 clinical trial of ZW251 for the treatment of hepatocellular carcinoma Achievement of $25.0 million development

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 Conference Call Scheduled for Friday, November 14, 2025 at 9:00 AM ET GlobeNewswire November 06, 2025 PORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets

LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that Heather Turner, Chief Executive Officer, will present at the Stifel 2025 Healthcare Conference in New York, NY on Thursday, November

Alector Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 06, 2025 Selected lead candidates AL137 for the company's Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson's disease; both advancing toward IND-enabling studies Advancing ABC-enabled Tau, Alpha Synuclein and

Cytek Biosciences to Participate in Upcoming Investor Conferences GlobeNewswire November 06, 2025 FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare Conference in Palm Beach, FLParticipating in investor 1×1 meetings

Trupanion Reports Strong Third Quarter 2025 Results and Secures New Credit Facility GlobeNewswire November 06, 2025 SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2025. “We delivered record quarterly profitability while

Pimentel appointed the first ever executive-in-residence for international cruise curriculum development, highlighting the importance of maritime hospitality education and Miami's role as the cruise capital of the world The Chaplin School of Hospitality & Tourism Management at Florida International University (FIU) today announced the appointment of luxury cruise veteran and highly-respected travel executive, Larry Pimentel,

ServiceTitan to Announce Fiscal Third Quarter 2026 Financial Results on December 4, 2025 GlobeNewswire November 06, 2025 LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal third quarter ended October 31, 2025, after

Tennessee Filmmaker and U.S. Marine Veteran Unite to Mobilize Support for Ukraine AIM Tell-A-Vision® Group (AIM TV), producers of the nationally syndicated TV series Raw Travel®, today announced the launch of Tennesseans for Ukraine, a new grassroots organization founded by Raw Travel creator and host Robert G. Rose and fellow Tennessean, U.S. Marine Veteran, and